Clover Health [CLOV] vs CVS Health [CVS] Detailed Stock Comparison
Clover Health
NASDAQ
Loading...
CVS Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Clover Health wins in 5 metrics, CVS Health wins in 13 metrics, with 0 ties. CVS Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Clover Health | CVS Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -31.50 | 19.11 | Clover Health |
| Price-to-Book Ratio | 3.87 | 1.12 | CVS Health |
| Debt-to-Equity Ratio | 0.00 | 106.67 | Clover Health |
| PEG Ratio | 0.10 | 10.59 | Clover Health |
| EV/EBITDA | -28.18 | 11.15 | Clover Health |
| Profit Margin (TTM) | -2.68% | 1.18% | CVS Health |
| Operating Margin (TTM) | -2.21% | 2.80% | CVS Health |
| EBITDA Margin (TTM) | N/A | 2.80% | N/A |
| Return on Equity | -12.59% | 5.88% | CVS Health |
| Return on Assets (TTM) | -4.26% | 2.29% | CVS Health |
| Free Cash Flow (TTM) | $33.29M | $6.33B | CVS Health |
| Dividend Yield | N/A | 3.01% | N/A |
| 1-Year Return | -21.86% | 21.58% | CVS Health |
| Price-to-Sales Ratio (TTM) | 0.83 | 0.23 | CVS Health |
| Enterprise Value | $1.16B | $155.73B | CVS Health |
| EV/Revenue Ratio | 0.72 | 0.41 | CVS Health |
| Gross Profit Margin (TTM) | 20.86% | 13.74% | Clover Health |
| Revenue per Share (TTM) | $3 | $305 | CVS Health |
| Earnings per Share (Diluted) | $-0.08 | $3.59 | CVS Health |
| Beta (Stock Volatility) | 1.92 | 0.59 | CVS Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Clover Health vs CVS Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Clover Health | 2.76% | 1.56% | -16.08% | -25.85% | -40.68% | -16.61% |
| CVS Health | 0.86% | 7.04% | 15.88% | 15.01% | 12.52% | 61.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Clover Health | -21.86% | -8.42% | -74.98% | -74.41% | -74.41% | -74.41% |
| CVS Health | 21.58% | -28.61% | 13.00% | -31.44% | 159.65% | 146.48% |
Performance & Financial Health Analysis: Clover Health vs CVS Health
| Metric | CLOV | CVS |
|---|---|---|
| Market Information | ||
| Market Cap | $1.34B | $87.01B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 11,461,635 | 6,343,070 |
| 90 Day Avg. Volume | 9,929,865 | 8,167,500 |
| Last Close | $2.61 | $71.43 |
| 52 Week Range | $2.12 - $4.87 | $43.56 - $72.51 |
| % from 52W High | -46.41% | -1.49% |
| All-Time High | $28.85 (Jun 07, 2021) | $113.65 (Jul 27, 2015) |
| % from All-Time High | -90.95% | -37.15% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.08% |
| Quarterly Earnings Growth | 0.34% | -0.42% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.01% |
| Operating Margin (TTM) | -0.02% | 0.03% |
| Return on Equity (TTM) | -0.13% | 0.06% |
| Debt to Equity (MRQ) | 0.00 | 106.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.67 | $61.07 |
| Cash per Share (MRQ) | $0.39 | $11.18 |
| Operating Cash Flow (TTM) | $-46,732,000 | $7.57B |
| Levered Free Cash Flow (TTM) | $83.15M | $5.83B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 3.01% |
| Last 12-Month Dividend | N/A | $2.01 |
Valuation & Enterprise Metrics Analysis: Clover Health vs CVS Health
| Metric | CLOV | CVS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -31.50 | 19.11 |
| Forward P/E | -18.64 | 10.59 |
| PEG Ratio | 0.10 | 10.59 |
| Price to Sales (TTM) | 0.83 | 0.23 |
| Price to Book (MRQ) | 3.87 | 1.12 |
| Market Capitalization | ||
| Market Capitalization | $1.34B | $87.01B |
| Enterprise Value | $1.16B | $155.73B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.72 | 0.41 |
| Enterprise to EBITDA | -28.18 | 11.15 |
| Risk & Other Metrics | ||
| Beta | 1.92 | 0.59 |
| Book Value per Share (MRQ) | $0.67 | $61.07 |
Financial Statements Comparison: Clover Health vs CVS Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CLOV | CVS |
|---|---|---|
| Revenue/Sales | $462.33M | $94.59B |
| Cost of Goods Sold | $353.44M | $80.19B |
| Gross Profit | $108.89M | $14.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-1.27M | $3.37B |
| EBITDA | $-808,000 | $4.56B |
| Pre-Tax Income | $-1.27M | $2.62B |
| Income Tax | N/A | $835.00M |
| Net Income (Profit) | $-1.27M | $1.78B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CLOV | CVS |
|---|---|---|
| Cash & Equivalents | $155.44M | $10.08B |
| Total Current Assets | $331.41M | $73.19B |
| Total Current Liabilities | $215.65M | $88.96B |
| Long-Term Debt | N/A | $73.63B |
| Total Shareholders Equity | $336.08M | $77.11B |
| Retained Earnings | $-2.20B | $63.77B |
| Property, Plant & Equipment | $5.03M | $28.56B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CLOV | CVS |
|---|---|---|
| Operating Cash Flow | $-24.27M | $3.96B |
| Capital Expenditures | $-185,000 | $-743.00M |
| Free Cash Flow | $-16.48M | $3.81B |
| Debt Repayment | N/A | $-743.00M |
| Common Stock Repurchase | $-31.96M | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | CLOV | CVS |
|---|---|---|
| Shares Short | 41.04M | 15.65M |
| Short Ratio | 4.25 | 1.83 |
| Short % of Float | 0.10% | 0.01% |
| Average Daily Volume (10 Day) | 11,461,635 | 6,343,070 |
| Average Daily Volume (90 Day) | 9,929,865 | 8,167,500 |
| Shares Outstanding | 503.53M | 1.26B |
| Float Shares | 400.28M | 1.27B |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 0.35% | 0.88% |
Dividend Analysis & Yield Comparison: Clover Health vs CVS Health
| Metric | CLOV | CVS |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.01 |
| Last 12-Month Dividend Yield | N/A | 3.01% |
| 3-Year Avg Annual Dividend | N/A | $2.28 |
| 3-Year Avg Dividend Yield | N/A | 0.87% |
| 3-Year Total Dividends | N/A | $6.85 |
| Ex-Dividend Date | N/A | Apr 22, 2025 |